Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE37.4700
- TODAY'S CHANGE (%)-1.5300 (-3.9231%)
- Bid / Lots35.0000/ 3
- Ask / Lots39.0000/ 1
- Open / Previous Close38.9100 / 39.0000
- Day Range
- 52 Week Range
- Volume414,877
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 793 | 38.91 |
| 09:34 ET | 1000 | 38.685 |
| 09:36 ET | 1539 | 38.6555 |
| 09:38 ET | 2312 | 38.65 |
| 09:45 ET | 200 | 38.565 |
| 09:50 ET | 100 | 38.51 |
| 09:56 ET | 200 | 38.18 |
| 09:57 ET | 400 | 37.99 |
| 10:01 ET | 2400 | 37.6735 |
| 10:03 ET | 2863 | 37.445 |
| 10:06 ET | 11101 | 37.47 |
| 10:08 ET | 800 | 37.835 |
| 10:15 ET | 1300 | 38.05 |
| 10:17 ET | 600 | 37.93 |
| 10:19 ET | 100 | 37.95 |
| 10:21 ET | 790 | 38.1 |
| 10:24 ET | 100 | 38.2 |
| 10:26 ET | 200 | 38.28 |
| 10:28 ET | 700 | 38.23 |
| 10:30 ET | 600 | 38.11 |
| 10:32 ET | 1500 | 38.09 |
| 10:35 ET | 3015 | 38.18 |
| 10:50 ET | 100 | 38.245 |
| 10:51 ET | 300 | 38.285 |
| 10:53 ET | 1356 | 38.37 |
| 10:55 ET | 100 | 38.55 |
| 11:02 ET | 300 | 38.485 |
| 11:06 ET | 100 | 38.55 |
| 11:08 ET | 4188 | 38.525 |
| 11:09 ET | 200 | 38.6 |
| 11:11 ET | 1100 | 38.665 |
| 11:13 ET | 100 | 38.67 |
| 11:15 ET | 1537 | 38.555 |
| 11:18 ET | 300 | 38.45 |
| 11:20 ET | 500 | 38.52 |
| 11:24 ET | 150 | 38.575 |
| 11:27 ET | 200 | 38.55 |
| 11:29 ET | 2517 | 38.5 |
| 11:31 ET | 1286 | 38.52 |
| 11:33 ET | 800 | 38.545 |
| 11:36 ET | 600 | 38.575 |
| 11:40 ET | 100 | 38.565 |
| 11:44 ET | 636 | 38.5 |
| 11:45 ET | 400 | 38.44 |
| 11:47 ET | 500 | 38.49 |
| 11:49 ET | 200 | 38.49 |
| 11:51 ET | 900 | 38.5 |
| 11:54 ET | 2164 | 38.46 |
| 11:58 ET | 4250 | 38.48 |
| 12:00 ET | 700 | 38.42 |
| 12:02 ET | 200 | 38.45 |
| 12:03 ET | 1400 | 38.5122 |
| 12:07 ET | 100 | 38.51 |
| 12:09 ET | 600 | 38.5 |
| 12:12 ET | 100 | 38.56 |
| 12:14 ET | 800 | 38.52 |
| 12:16 ET | 800 | 38.49 |
| 12:18 ET | 2800 | 38.66 |
| 12:21 ET | 300 | 38.645 |
| 12:23 ET | 1137 | 38.52 |
| 12:25 ET | 100 | 38.54 |
| 12:27 ET | 400 | 38.61 |
| 12:30 ET | 500 | 38.68 |
| 12:32 ET | 300 | 38.67 |
| 12:34 ET | 1062 | 38.59 |
| 12:36 ET | 1600 | 38.59 |
| 12:38 ET | 144 | 38.64 |
| 12:39 ET | 200 | 38.63 |
| 12:41 ET | 1900 | 38.69 |
| 12:43 ET | 1400 | 38.645 |
| 12:45 ET | 700 | 38.725 |
| 12:48 ET | 1100 | 38.795 |
| 12:50 ET | 810 | 38.74 |
| 12:52 ET | 100 | 38.82 |
| 12:54 ET | 300 | 38.75 |
| 12:56 ET | 1200 | 38.74 |
| 12:57 ET | 200 | 38.76 |
| 01:01 ET | 416 | 38.67 |
| 01:03 ET | 700 | 38.67 |
| 01:06 ET | 1113 | 38.61 |
| 01:08 ET | 300 | 38.62 |
| 01:10 ET | 200 | 38.6 |
| 01:12 ET | 100 | 38.63 |
| 01:14 ET | 2316 | 38.63 |
| 01:15 ET | 100 | 38.61 |
| 01:17 ET | 400 | 38.61 |
| 01:19 ET | 200 | 38.59 |
| 01:21 ET | 100 | 38.59 |
| 01:24 ET | 100 | 38.61 |
| 01:26 ET | 1543 | 38.61 |
| 01:28 ET | 400 | 38.63 |
| 01:30 ET | 800 | 38.7 |
| 01:32 ET | 100 | 38.67 |
| 01:33 ET | 100 | 38.77 |
| 01:35 ET | 500 | 38.66 |
| 01:37 ET | 200 | 38.77 |
| 01:39 ET | 100 | 38.68 |
| 01:42 ET | 1033 | 38.63 |
| 01:44 ET | 100 | 38.63 |
| 01:50 ET | 333 | 38.64 |
| 01:51 ET | 200 | 38.6 |
| 01:53 ET | 400 | 38.54 |
| 01:55 ET | 870 | 38.4 |
| 01:57 ET | 1294 | 38.4 |
| 02:00 ET | 2100 | 38.4 |
| 02:02 ET | 800 | 38.4 |
| 02:04 ET | 500 | 38.4 |
| 02:06 ET | 500 | 38.4 |
| 02:08 ET | 1100 | 38.43 |
| 02:09 ET | 3862 | 38.4 |
| 02:11 ET | 6650 | 38.26 |
| 02:13 ET | 1192 | 38.32 |
| 02:18 ET | 100 | 38.29 |
| 02:20 ET | 2553 | 38.41 |
| 02:24 ET | 100 | 38.31 |
| 02:27 ET | 100 | 38.22 |
| 02:29 ET | 300 | 38.12 |
| 02:31 ET | 150 | 38.16 |
| 02:33 ET | 100 | 38.1 |
| 02:36 ET | 349 | 38.09 |
| 02:42 ET | 395 | 37.995 |
| 02:45 ET | 2845 | 38.08 |
| 02:49 ET | 400 | 38.11 |
| 02:51 ET | 1128 | 38.1375 |
| 02:54 ET | 616 | 38.17 |
| 02:56 ET | 250 | 38.165 |
| 03:00 ET | 3847 | 38.075 |
| 03:02 ET | 119 | 38.04 |
| 03:03 ET | 700 | 38 |
| 03:05 ET | 142 | 37.93 |
| 03:09 ET | 600 | 38 |
| 03:12 ET | 250 | 37.975 |
| 03:16 ET | 900 | 38.14 |
| 03:18 ET | 500 | 38.03 |
| 03:20 ET | 100 | 38 |
| 03:21 ET | 100 | 38.035 |
| 03:23 ET | 361 | 37.985 |
| 03:25 ET | 505 | 38.05 |
| 03:27 ET | 100 | 38.05 |
| 03:30 ET | 200 | 38.01 |
| 03:32 ET | 200 | 38.015 |
| 03:34 ET | 2342 | 38 |
| 03:36 ET | 3121 | 37.89 |
| 03:38 ET | 400 | 37.79 |
| 03:39 ET | 533 | 37.865 |
| 03:41 ET | 200 | 37.84 |
| 03:45 ET | 899 | 37.815 |
| 03:48 ET | 612 | 37.84 |
| 03:50 ET | 700 | 37.815 |
| 03:52 ET | 1240 | 37.67 |
| 03:54 ET | 4673 | 37.47 |
| 03:56 ET | 3545 | 37.41 |
| 03:57 ET | 6439 | 37.39 |
| 03:59 ET | 17159 | 37.47 |
May 28, 2024
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD, from 7:30AM ET on Tuesday May 28, 2024 by Dow Jones
7:30AM ET on Tuesday May 28, 2024 by Dow JonesPress Release: Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD, from 7:30AM ET on Tuesday May 28, 2024 by Dow Jones
7:30AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 2.3B | -18.3x | --- |
Iovance Biotherapeutics Inc | 2.3B | -4.7x | --- |
Janux Therapeutics Inc | 2.2B | -33.9x | --- |
Rocket Pharmaceuticals Inc | 2.2B | -8.3x | --- |
Celldex Therapeutics Inc | 2.4B | -12.7x | --- |
CG Oncology Inc | 2.1B | -27.9x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark McKenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Lisa Bollinger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.04 |
Book Value | $7.86 |
P/E Ratio | -18.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
